Allient price target lowered to $30 from $41 at Craig-Hallum

Craig-Hallum lowered the firm’s price target on Allient to $30 from $41 and keeps a Buy rating on the shares following the quarterly results. Management is aggressively cutting costs which should limit some downside but understands this is an environment with little visibility and lots of uncertainty, the analyst tells investors in a research note.